Specialising in intellectual property matters within the life sciences sector, the team at Westerberg & Partners remains active, advising a range of pharma and healthcare companies. Jonas Löfgren heads the group, where he has extensive experience in market access, compliance, and agreement drafting within the sector. Ludvig Holm is another notable name within the team, being a key contact for patent litigation and wider trademark mandates. Björn Rundblom Andersson is well placed to handle trade secrets and license agreements disputes.
Legal 500 Editorial commentary
Key clients
- Alnylam Pharmaceuticals
- Novartis
- Dr. Wolff Group
- Karo Pharma
- Permobil Group
Work highlights
Advised Dr. Wolf Group on the market access in Sweden of its first medicinal product, Axhidrox
Advising Karo Pharma Group subsidiaries Karo Healthcare and CCS Skincare brands in the Swedish Patent & Market Court against a claim from Footmender AB that the claims used for promoting the products are medical and thus would require a classification as a medicinal product or medical device of the products.
Practice head
Jonas Löfgren
Other key lawyers
Björn Rundblom Andersson; Ludvig Holm